January 19, 2022
2 min watch
Save
VIDEO: AcuFocus executive on what ‘approvable letter’ means for IC-8 IOL
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
WAIKOLOA, Hawaii — Yari L. Mitchell, chief business development officer at AcuFocus, updates the approval process and progress for the IC-8 small aperture IOL.
“We recently received an ‘approvable letter’ from the FDA, which we are incredibly excited about,” Mitchell said here at Hawaiian Eye 2022. “What this means, is that the agency has received our PMA, has reviewed it, and we have met the requirements for approval.”